These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38451979)

  • 21. Cognitive adverse effects of epilepsy and its predictors attending outpatient department of South Gondar zone hospitals, Amhara Region, Ethiopia 2020 /2021.
    Asnakew S; Legas G; Belete A; Admasu FT; Yitbarek GY; Aytenew TM; Demise B; Alemu EM; Alemu MA; Bayih WA; Feleke DG; Chanie ES; Birhane BM; Kefale D
    PLoS One; 2022; 17(12):e0278908. PubMed ID: 36490273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.
    Smith MC; Klein P; Krauss GL; Rashid S; Seiden LG; Stern JM; Rosenfeld WE
    Neurol Ther; 2022 Dec; 11(4):1705-1720. PubMed ID: 36057761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy problems, medication adherence and treatment satisfaction among diabetic patients on follow-up care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Demoz GT; Berha AB; Alebachew Woldu M; Yifter H; Shibeshi W; Engidawork E
    PLoS One; 2019; 14(10):e0222985. PubMed ID: 31574113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Effects of Antiseizure Medications.
    LoPinto-Khoury C
    Semin Neurol; 2022 Oct; 42(5):583-593. PubMed ID: 36216358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacotherapy of epilepsy--current problems and controversies].
    Schmidt D
    Fortschr Neurol Psychiatr; 1983 Nov; 51(11):363-86. PubMed ID: 6418628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epilepsy Treatment Outcome and Its Predictors among Ambulatory Patients with Epilepsy at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia.
    Zewudie A; Mamo Y; Feyissa D; Yimam M; Mekonen G; Abdela A
    Neurol Res Int; 2020; 2020():8109858. PubMed ID: 32328306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multicenter, Cross-Sectional, Observational Study on Epilepsy and its Management Practices in India.
    Mehndiratta MM; Kukkuta Sarma GR; Tripathi M; Ravat S; Gopinath S; Babu S; Mishra UK
    Neurol India; 2022; 70(5):2031-2038. PubMed ID: 36352605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of adults and children following a first unprovoked seizure.
    Neligan A; Adan G; Nevitt SJ; Pullen A; Sander JW; Bonnett L; Marson AG
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013847. PubMed ID: 36688481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and associated factors of medication-related problems among epileptic patients at ambulatory clinic of Mettu Karl Comprehensive Specialized Hospital: a cross-sectional study.
    Bekele F; Mamo T; Fekadu G
    J Pharm Policy Pract; 2022 Oct; 15(1):71. PubMed ID: 36303258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of COVID-19 on treatment follow-up and medication adherence among patients with epilepsy at a referral hospital in Ethiopia.
    Tekleyohannes BA; Yifru YM; Nasir BB
    PLoS One; 2024; 19(2):e0299065. PubMed ID: 38408069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis.
    Janmohamed M; Hakeem H; Ooi S; Hakami S; Vu L; Perucca P; O'Brien TJ; Antonic-Baker A; Chen Z; Kwan P
    CNS Drugs; 2023 Jan; 37(1):13-30. PubMed ID: 36542274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to antiseizure medications in an underserved population with epilepsy.
    Gonzalez A; Pandey D; Digiannantonio N; Serafini A
    Epilepsy Behav; 2023 Dec; 149():109484. PubMed ID: 37988904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and associated factors among patients with epilepsy at specialized hospitals, Northwest Ethiopia; 2019.
    Minwuyelet F; Mulugeta H; Tsegaye D; Lake B; Getie A; Tsegaye B; Mullu G
    PLoS One; 2022; 17(1):e0262814. PubMed ID: 35085331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and factors associated with drug therapy problems among hypertensive patients at hypertension clinic of Mbarara Regional Referral Hospital, Uganda: a |cross-sectional study.
    Babirye M; Yadesa TM; Tamukong R; Obwoya PS
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231160319. PubMed ID: 37036058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
    Sperling MR; Klein P; Aboumatar S; Gelfand M; Halford JJ; Krauss GL; Rosenfeld WE; Vossler DG; Wechsler R; Borchert L; Kamin M
    Epilepsia; 2020 Jun; 61(6):1099-1108. PubMed ID: 32396252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.